Claris receives PAS for Furosemide injection in US
The company had received the original approval for this ANDA in January 2014 and was selling the products in the US in 2014
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA
Ajanta Pharma gets approvals for three ANDAs
Montelukast tablets are indicated for the treatment of prophylaxis and chronic treatment of asthma and to relieve symptoms of…
SPARC receives CRL from US FDA for Latanoprost NDA
The product will be manufactured at SPIL’s Halol facility
Sun Pharma Advanced Research Company (SPARC) announced that the US Food…
Unichem recalls one lot of hypertension drug in US
The recall has been initiated as a precautionary measure due to the identification of a clopidogrel tablet found in a bottle of…
DRL announces launch of memantine hydrochloride tablets, USP
It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market
Jubilant Life Sciences receives ANDA approval for Levofloxacin tabs
It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin…
Aurobindo Pharma receives approval for Azithromycin for injection and Entacapone tabs
Azithromycin for injection is indicated for treatment of patients with community-acquired pneumonia and pelvic inflammatory…
Data integrity … dil se
Two reports, released in early June, have both good news and bad news for the pharma industry in India
Glenmark receives tentative ANDA approval for Calcipotriene cream, 0.005 per cent
Dovonex is indicated for the treatment of plaque psoriasis
Aurobindo Pharma receives US FDA approval
Atracurium Besylate injections are indicated as an adjunct to general anaesthesia